Page last updated: 2024-08-17

methionine and MEA 2b

methionine has been researched along with MEA 2b in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cote, G; Grubbs, EG; Habra, MA; Hu, MI; Jasim, S; Jimenez, C; Rich, TA; Waguespack, SG; Ying, AK1
Fukuda, Y; Imai, Y; Kurihara, R; Shinohara, S; Takenobu, T; Toyosawa, S; Usami, Y1
Amosenko, FA; BrzhezovskiÄ­, VZh; Gar'kavtseva, RF; Kalinin, VN; Kazubskaia, TP; Kozlova, VM; Liubchenko, LN; Shabanov, MA; Vanushko, VE1
Komminoth, P1
Cote, GJ; Gagel, RF; Kahn, MA1
Carlomagno, F; Cirafici, AM; Dathan, NA; De Vita, G; Fusco, A; Melillo, RM; Salvatore, G; Santoro, M; Visconti, R1

Reviews

1 review(s) available for methionine and MEA 2b

ArticleYear
RET protooncogene mutational analysis in multiple endocrine neoplasia syndrome type 2B: case report and review of the literature.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1996, Volume: 82, Issue:3

    Topics: Carcinoma, Medullary; Child; Chromosomes, Human, Pair 10; DNA Mutational Analysis; DNA, Neoplasm; Drosophila Proteins; Germ-Line Mutation; Humans; Male; Methionine; Multiple Endocrine Neoplasia Type 2b; Neurofibroma; Point Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Threonine; Thyroid Neoplasms; Thyroidectomy; Tongue Neoplasms

1996

Other Studies

5 other study(ies) available for methionine and MEA 2b

ArticleYear
Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.
    Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:2

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Alanine; Carcinoma, Neuroendocrine; Female; Germ-Line Mutation; Humans; Methionine; Multiple Endocrine Neoplasia Type 2b; Phenylalanine; Pheochromocytoma; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Risk Factors; Threonine; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome

2011
Neural hyperplasia in maxillary bone of multiple endocrine neoplasia type 2B patient.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 112, Issue:6

    Topics: Adolescent; Amino Acid Substitution; Carcinoma, Medullary; Codon; Cornea; Exons; Humans; Hyperplasia; Lymphatic Metastasis; Male; Maxilla; Megacolon; Methionine; Mouth Neoplasms; Multiple Endocrine Neoplasia Type 2b; Mutation; Neuroma; Open Bite; Osteotomy, Le Fort; Proto-Oncogene Proteins c-ret; Schwann Cells; Threonine; Thyroid Neoplasms

2011
[Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
    Genetika, 2003, Volume: 39, Issue:6

    Topics: Adolescent; Adult; Aged; Carcinoma, Medullary; Exons; Female; Humans; Male; Methionine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Pedigree; Pheochromocytoma; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Russia; Threonine; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy

2003
Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1995, Volume: 79

    Topics: Adrenal Gland Neoplasms; Awards and Prizes; Codon; Cysteine; Diagnosis, Differential; Drosophila Proteins; Genetic Carrier Screening; Humans; Hyperplasia; Methionine; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Pathology; Pheochromocytoma; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Threonine; Thyroid Neoplasms

1995
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential.
    Endocrinology, 1997, Volume: 138, Issue:4

    Topics: 3T3 Cells; Animals; Carcinoma, Medullary; Cell Transformation, Neoplastic; Drosophila Proteins; Enzyme Activation; Methionine; Mice; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Phosphorylation; Point Mutation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship; Thyroid Neoplasms; Transfection

1997